Bausch Health Companies Inc. (BHC)

Bausch Health Companies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-592	-225	-948	-560	-1,788
Depreciation & Amortization	1,264	1,394	1,552	1,825	2,075
Share-Based Compensation	132	126	128	105	102
Other Operating Activities	228	-2,023	694	-259	1,112
Operating Cash Flow	1,032	-728	1,426	1,111	1,501
Operating Cash Flow Growth	-	-	28.35%	-25.98%	0%
Capital Expenditures	-272	-268	-283	-309	-278
Acquisitions	-1,885	-40	669	21	-135
Change in Investments	-1	5	-4	4	-6
Other Investing Activities	13	-	27	23	-
Investing Cash Flow	-2,145	-303	409	-261	-419
Share Issuance / Repurchase	-24	-31	-52	-30	-40
Debt Issued / Paid	1,545	-1,081	-1,388	-2,226	1,526
Other Financing Activities	-46	638	-73	-38	-43
Financing Cash Flow	1,475	-474	-1,513	-2,294	1,443
Exchange Rate Effect	9	-23	-19	16	-4
Net Cash Flow	371	-1,528	303	-1,428	2,521
Free Cash Flow	760	-996	1,143	802	1,223
Free Cash Flow Growth	-	-	42.52%	-34.42%	-3.40%
Free Cash Flow Margin	8.68%	-12.26%	13.55%	9.99%	14.22%
Free Cash Flow Per Share	2.08	-2.75	3.19	2.26	3.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).